380560-89-4

380560-89-4 structure

Name: DQP 1105
Chemical Name: 4-[5-(4-Bromophenyl)-3-(6-methyl-2-oxo-4-phenyl-1,2-dihydro-3-qui nolinyl)-4,5-dihydro-1H-pyrazol-1-yl]-4-oxobutanoic acid
CAS Number: 380560-89-4
Molecular Formula: C₂₉H₂₄BrN₃O₄
Molecular Weight: 558.42300
Create Date: 2017-10-10 20:00:24
Modify Date: 2024-01-24 14:01:14
DQP-1105 is a potent noncompetitive NMDA receptor antagonist. DQP-1105 inhibits GluN2C- and GluN2D-containing receptors (IC50=7.0 and 2.7 μM, respectively). The IC50 values are at least 50-fold lower than those for recombinant GluN2A-, GluN2B-, GluA1-, or GluK2-containing receptors[1].

Name	4-[5-(4-Bromophenyl)-3-(6-methyl-2-oxo-4-phenyl-1,2-dihydro-3-qui nolinyl)-4,5-dihydro-1H-pyrazol-1-yl]-4-oxobutanoic acid

Description	DQP-1105 is a potent noncompetitive NMDA receptor antagonist. DQP-1105 inhibits GluN2C- and GluN2D-containing receptors (IC50=7.0 and 2.7 μM, respectively). The IC50 values are at least 50-fold lower than those for recombinant GluN2A-, GluN2B-, GluA1-, or GluK2-containing receptors[1].
Related Catalog	Signaling Pathways >> Neuronal Signaling >> iGluR Research Areas >> Neurological Disease Signaling Pathways >> Membrane Transporter/Ion Channel >> iGluR
References	[1]. Acker TM, et al. Mechanism for noncompetitive inhibition by novel GluN2C/D N-methyl-D-aspartate receptor subunit-selective modulators. Mol Pharmacol. 2011;80(5):782-795.